Meyka Pro banner
Femasys Inc.

Femasys Inc. (FEMY) Stock Overview

Explore Femasys Inc.’s financial performance, market position, analyst ratings, and future outlook.

FEMYNASDAQ
HealthcareMedical - Instruments & Supplies
$3.71
$0.08(2.11%)
U.S. Market opens in 14h 26m

Femasys Inc. (FEMY)

Meyka AI Score

Z

Key Financials

Market Cap11.2M
P/E Ratio-0.57
EPS (TTM)$-0.36
ROE-2.58%
Fundamental Analysis

AI Price Forecasts

1 Month$2.94
3 Months$6.99
1 Year Target$5.43

FEMY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Femasys Inc. (NASDAQ: FEMY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Femasys Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of FEMY on the NASDAQ shows an RSI of 44.08, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.43 for the NASDAQ listing.

Key metrics behind Femasys Inc.'s NASDAQ-traded stock include a P/E ratio of -0.57 and a market capitalization of 11.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FEMY on the NASDAQ.

Price Performance (NASDAQ: FEMY)

1-Day Change
-2.11%
5-Day Change
18.53%
1-Month Change
1.09%
3-Month Change
-54.42%
6-Month Change
-70.34%
Year-to-Date (YTD) Change
-67.80%
1-Year Change
-79.73%
3-Year Change
-51.06%
5-Year Change
-97.51%
All-Time (Max) Change
-98.45%

Contact Information

770 500 3910
3950 Johns Creek Court, Suwanee, GA, 30024

Company Facts

540 Employees
IPO DateJun 18, 2021
CountryUS
Actively Trading

Frequently Asked Questions